Mutations affecting members of the RAS family genes (KRAS, HRAS, NRAS) are the most frequent genetic alterations in human cancer, affecting about 27% of all tumors, including lung, colorectal and pancreatic ductal adenocarcinoma, among others (2, 3). The gene discussed is KRAS; the disease is cancer.